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Abstract
The malate–aspartate shuttle is indispensable for the net
transfer of cytosolic NADH into mitochondria to maintain a high
rate of glycolysis and to support rapid tumor cell growth. The
malate–aspartate shuttle is operated by two pairs of enzymes
that localize to the mitochondria and cytoplasm, glutamate
oxaloacetate transaminases (GOT), and malate dehydrogenases
(MDH). Here, we show that mitochondrial GOT2 is acetylated
and that deacetylation depends on mitochondrial SIRT3. We
have identified that acetylation occurs at three lysine residues,
K159, K185, and K404 (3K), and enhances the association
between GOT2 and MDH2. The GOT2 acetylation at these three
residues promotes the net transfer of cytosolic NADH into
mitochondria and changes the mitochondrial NADH/NAD+ redox
state to support ATP production. Additionally, GOT2 3K acetyla-
tion stimulates NADPH production to suppress ROS and to
protect cells from oxidative damage. Moreover, GOT2 3K acety-
lation promotes pancreatic cell proliferation and tumor growth
in vivo. Finally, we show that GOT2 K159 acetylation is increased
in human pancreatic tumors, which correlates with reduced
SIRT3 expression. Our study uncovers a previously unknown
mechanism by which GOT2 acetylation stimulates the malate–
aspartate NADH shuttle activity and oxidative protection.
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Introduction
The glycolytic pathway is of great importance for energy production
in the cell. During the breakdown of glucose to pyruvate, the coen-
zyme NAD+ (nicotinamide adenine dinucleotide, oxidized form) is
reduced to NADH, and rapid oxidation of NADH to regenerate
NAD+ is equally important for the cell to ensure glycolysis to
proceed. Oxidation of cytosolic NADH can be achieved by anaerobic
respiration that drives the reduction of pyruvate to lactate, or by
aerobic respiration and the transfer of electrons via the mitochon-
drial electron transport chain (ETC). However, the transfer of
NADH into mitochondria is hindered by the impermeability of the
inner mitochondrial membrane to NADH (Lehninger, 1951). There-
fore, the malate–aspartate shuttle plays an important role in trans-
ferring reducing equivalents across the mitochondrial membrane for
energy production. Supporting this notion, the malate–aspartate
shuttle has been shown to be the major way for the net transfer
of cytosolic NADH into mitochondria in rat heart and liver
(Williamson et al, 1970, 1971; Safer et al, 1971). Moreover, the
malate–aspartate shuttle has been reported to oxidize 20–80% of
cytosolic NADH in Ehrlich ascites tumor cells, Krebs II carcinoma,
AS-30D carcinoma and L1210 cells (Dionisi et al, 1974; Greenhouse
& Lehninger, 1977).
The malate–aspartate shuttle is operated by two pairs of
enzymes, mitochondrially and cytoplasmically localized glutamate
oxaloacetate transaminases (GOT) and malate dehydrogenases
(MDH), which act in concert to transfer reducing equivalents across
the mitochondrial membrane, with no net movement of carbon or
nitrogen (Barron et al, 1998). As shown in Fig 1A, cytoplasmic
MDH1 reduces oxaloacetate (OAA) to malate while oxidizing
NADH to NAD+. Malate is then transported to the interior of the
mitochondrion in exchange for a-ketoglutarate (a-KG). Inside the
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mitochondrion, malate is oxidized once again to OAA by mitochon-
drial MDH2, giving rise to NADH which enters the ETC to produce
ATP. In return, mitochondrial GOT2 converts OAA inside the
mitochondrion to aspartate by transamination, with the amino
group being donated by glutamate, giving rise to a-KG. Aspartate
and a-KG then enter the cytosol, wherein aspartate is converted to
OAA, while a-KG is converted to glutamate mediated by GOT1.
Earlier studies have suggested that GOT may interact with MDH in
both the cytosol and the mitochondrion (Backman & Johansson,
1976). Moreover, it has been proposed that GOT and MDH may
form some substrate channelling for the transit of OAA in cells
(Bryce et al, 1976; Arrio-Dupont et al, 1985). This may explain the
absence of high OAA accumulation in rat liver cells (Williamson
et al, 1969; Parrilla et al, 1975; Siess et al, 1977). However, very
little is known about the formation of the GOT-MDH complex in
response to metabolic changes and about the physiological signifi-
cance of such a regulation.
We and others have previously discovered that lysine acetylation
is an evolutionarily conserved post-translational modification in the
regulation of a wide range of cellular processes, particularly in
nuclear transcription and cytoplasmic metabolism (Kim et al, 2006;
Choudhary et al, 2009; Zhao et al, 2010). To date, more than 4,500
acetylated proteins have been identified (Lundby et al, 2012).
Among these acetylated proteins is MDH2, in which as many as four
lysine residues are acetylated, and acetylation has been shown to
activate MDH2 (Zhao et al, 2010). The other mitochondrial compo-
nent of the malate–aspartate shuttle, GOT2, is also acetylated
(Choudhary et al, 2009; Zhao et al, 2010). In this report, we investi-
gated GOT2 acetylation and its functional significance in controlling
the malate–aspartate shuttle activity in the cell.
Results
Acetylation of GOT2 at K159, K185 and K404 enhances its binding
with MDH2
Previous proteomic analyses based on mass spectrometry have
identified a large number of acetylated proteins, including GOT2
(Choudhary et al, 2009; Zhao et al, 2010). To confirm this, we
transfected Flag-GOT2 into HEK293T cells and examined the acety-
lation of GOT2 by Western blotting using a pan-anti-acetyllysine
antibody. We found that GOT2 was indeed acetylated and its acety-
lation was enhanced by approximately 2.5-fold after 4 h of treat-
ment with nicotinamide (NAM), an inhibitor of the SIRT family
deacetylases (Bitterman et al, 2002; Avalos et al, 2005) (Fig 1B).
Treatment with Trichostatin A (TSA), an inhibitor of histone
deacetylase HDAC I and II (Furumai et al, 2001), did not substan-
tially affect GOT2 acetylation (Fig 1B), and additional treatment
with TSA did not further change the acetylation level of GOT2 in
cells co-treated with NAM (Fig 1C). These results indicate that
GOT2 is acetylated and is regulated by a member of the SIRT family
of deacetylases.
A previous study has shown that GOT may interact with MDH
both in the cytosol and in the mitochondrion (Backman &
Johansson, 1976). We thus tested the protein association between
ectopically expressed Flag-GOT2 and Myc-MDH2 in HEK293T cells.
We found the protein interaction between Flag-GOT2 and
Myc-MDH2 was extremely weak, hardly to be detected (Fig 1D).
Notably, the GOT2–MDH2 association was substantially enhanced
by NAM treatment (Fig 1D). Likewise, the association of Flag-GOT2
with endogenous MDH2 and that of Flag-MDH2 with endogenous
GOT2 were hardly detectable in HEK293T, but were greatly
enhanced by NAM treatment (Fig 1E and F). These results suggest
that GOT2–MDH2 association is promoted by acetylation and nega-
tively regulated by a SIRT-mediated deacetylation.
As noted in the introduction, we have previously identified four
major regulatory sites targeted by acetylation in MDH2, including
K185, K301, K307, and K314 (4K) (Zhao et al, 2010). When Flag-
tagged wild-type and the acetylation-deficient 4KR mutant MDH2
were overexpressed in HEK293T cells, we found that both wild-type
and 4KR mutant MDH2 hardly interacted with endogenous GOT2
(Supplementary Fig S1). Interestingly, the 4KR mutant MDH2
displayed negligible response in changing acetylation level after
NAM treatment, but still exhibited enhanced protein interaction
with endogenous GOT2 (Supplementary Fig S1), suggesting that the
observed effect of NAM on promoting GOT2–MDH2 association is
most likely accomplished by increasing the acetylation of GOT2, but
not MDH2.
Given that GOT2 is a conserved protein among the species of
Homo sapiens, Mus musculus, Xenopus tropicalis, and Danio rerio
(Supplementary Fig S2), we speculated that important regulatory
sites targeted by acetylation might also be conserved. Sequence
alignments from diverse species revealed that the 14 putative
acetylated lysine residues are invariant (Supplementary Fig S2)
(Choudhary et al, 2009). To determine which lysine residue(s) plays
a major role in the regulation of GOT2 and/or its association with
MDH2, we divided these 14 putative acetylated residues into six
groups according to their position in the structure of GOT2 (Fig 1G;
Supplementary Fig S3A–E). We mutated each group of putative acet-
ylated lysine (K) sites to arginine (R) or glutamine (Q) and exam-
ined the protein association of each group of GOT2 mutants with
ectopically expressed Myc-MDH2. The K-to-R mutation retains a
positive charge and is often used as a deacetylated mimic, whereas
the K-to-Q mutation abolishes the positive charge and may act as a
surrogate of acetylation (Megee et al, 1990). In agreement with our
earlier finding in Fig 1D, the interaction between wild-type GOT2
and MDH2 was significantly enhanced by 5 h of NAM treatment
(Fig 1H). Strikingly, simultaneous mutation of three putative acety-
lation lysine residues, K159, K185, and K404, to similarly positively
charged arginine (3KR) in GOT2 disrupted its binding with MDH2 in
cells even after NAM treatment (Fig 1H). The association with
MDH2 was not or only mildly affected by single or double K-to-R
mutation targeting K159, K185, or K404 in the GOT2 protein
(Supplementary Fig S4A and B).
To provide further evidence supporting the role of acetylation in
promoting GOT2–MDH2 association, we generated an antibody
specifically recognizing the K159-acetylated GOT2 [a-acGOT2
(K159)] (Supplementary Fig S5A–C). We then transfected HEK293T
cells either singularly with plasmid expressing Flag-GOT2 or both
Flag-GOT2 and Myc-MDH2 plasmids. Transfected cells were treated
with SIRT inhibitor NAM for 5 h prior to lysis to increase acetylated
GOT2. Lysates from both cells were subjected to double immuno-
precipitations, first with the Myc antibody and then with the Flag
antibody in supernatants depleted by the Myc antibody. We found
that Flag-GOT2 was detected in Myc precipitates from Flag-GOT2
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and Myc-MDH2 co-transfected cells (top panel, lane 2, Fig 1I), but
not in cells transfected with Flag-GOT2 alone (top panel, lane 1),
demonstrating the specificity of GOT2–MDH2 association. Impor-
tantly, K159-acetylated GOT2 was readily detected in Myc precipi-
tates from Flag-GOT2 and Myc-MDH2 co-transfected cells, but was
not seen in supernatants of the same cell lysate after Myc depletion.
This result indicates that nearly all K159-acetylated GOT2 is in the
complex with MDH2.
To determine whether acetylation of these three sites (K159,
K185, and K404) would affect the enzyme activity of GOT2, we
employed an expression system genetically encoding Ne-acetyllysine
to prepare recombinant K159-acetylated GOT2 protein in E. coli
(Neumann et al, 2008, 2009), which produced recombinant protein
with complete acetylation at the targeted lysine residue. Using the
a-acGOT2(K159) antibody, we verified the incorporation of acetylly-
sine at K159 (Supplementary Fig S5D). By monitoring the produc-
tion of glutamate, we found that the purified GOT2K159ac displayed
identical enzyme activity as compared to wild-type proteins (Supple-
mentary Fig S5D). We then ectopically expressed and purified from
E. coli both 3KR and 3KQ mutant GOT2 proteins and examined their
enzymatic activity. We found that 3K mutations did not change
GOT2 enzyme activity (Fig 1J). Taken together, these results suggest
that GOT2 3K acetylation can enhance the protein association
between GOT2 and MDH2 without affecting GOT2 enzyme activity.
Glucose and glutamine promote GOT2 acetylation and GOT2–
MDH2 association
Both glucose and glutamine are the major carbon and energy
sources for cultured mammalian cells. When Panc-1 cells were
treated with high glucose or glutamine, we observed a significant
increase in the mitochondrial NADH level (Supplementary Fig S6A
and B). This raises the possibility that glucose or glutamine may
affect the activity of the malate–aspartate shuttle activity, thereby
influencing the net transfer of cytosolic NADH into mitochondria.
Supporting this notion, a previous study has shown that the activity
of the malate–aspartate shuttle in the rat heart was greatly elevated
by glutamate, the deaminated product of glutamine (Digerness &
Reddy, 1976). Moreover, a recent study has reported that inhibition
of the malate–aspartate shuttle by aminooxyacetate (AOA) can
hinder the effect of high glucose on increasing mitochondrial NADH
(Zhao et al, 2011). These findings suggest that the malate–aspartate
NADH shuttle may act as a sensor of energy status that maintains
cellular energy homeostasis.
We next set out to investigate whether acetylation of GOT2 at 3K
is involved in the regulation of the malate–aspartate shuttle activity
in cells exposed to high glucose and glutamine. In HEK293T cells
transiently co-overexpressing Flag-GOT2 and Myc-MDH2, we found
that glucose increased the K159 acetylation level of Flag-GOT2 in a
dose-dependent manner and that the increased K159 acetylation of
GOT2 was in parallel with enhanced GOT2–MDH2 association after
glucose treatment (Fig 2A). Likewise, high glutamine increased the
K159 acetylation level of Flag-GOT2 in a dose-dependent manner
(Fig 2B), and again, the increased K159 acetylation of GOT2 was
associated with enhanced GOT2–MDH2 interaction after glutamine
treatment (Fig 2B). These results suggest that GOT2 3K acetylation
can regulate the malate–aspartate shuttle activity through modulat-
ing GOT2–MDH2 association under physiological conditions.
Pancreatic ductal adenocarcinoma cancer (PDAC) is highly sensi-
tive to glucose and glutamine deprivation (Ying et al, 2012; Son
et al, 2013). In addition to a well-known glutamine metabolism
pathway mediated by glutamate dehydrogenase (GLUD1), PDAC
relies on a novel pathway for glutamine metabolism in which gluta-
mate transaminases GOT1 and GOT2 are involved (Son et al, 2013).
We next determined the regulation of GOT2 K159 acetylation by
glucose and glutamine in Panc-1, a pancreatic cancer cell line. We
Figure 1. Acetylation of GOT2 at K159, K185, and K404 enhances its protein interaction with MDH2.
A Cartoon representation of the malate–aspartate shuttle. As shown, this shuttle is operated by two pairs of enzymes, cytosolic GOT1 and MDH1 as well as
mitochondrial GOT2 and MDH2, which act in concert to transfer reducing equivalents across the mitochondrial membrane.
B, C GOT2 can be acetylated. Flag-tagged GOT2 was ectopically expressed in HEK293T cells treated with NAM (5 mM) and/or TSA (0.5 mM) for the indicated time period.
Acetylation levels of Flag-bead-purified GOT2 were determined by Western blot analysis using a pan-anti-acetyllysine antibody (a-Ac). IB and IP denote
immunoblotting and immunoprecipitation, respectively. Relative GOT2 acetylation ratios were calculated after normalizing against Flag.
D GOT2 acetylation enhances the interaction between ectopically expressed GOT2 and MDH2. Flag-GOT2 and Myc-MDH2 were co-overexpressed in HEK293T cells
treated without or with NAM (5 mM) for the indicated time period. The acetylation level of Flag-bead-purified GOT2 and the protein association between ectopic
proteins of GOT2 and MDH2 were determined by Western blot analysis.
E Acetylation enhances the interaction between ectopically expressed GOT2 and endogenous MDH2. Flag-GOT2 was co-overexpressed in HEK293T cells treated
without or with NAM (5 mM) for the indicated time period. The acetylation level of Flag-GOT2 and its association with endogenous MDH2 were determined by
Western blot analysis.
F Acetylation enhances the interaction between ectopically expressed MDH2 and endogenous GOT2. Flag-MDH2 was co-overexpressed in HEK293T cells treated
without or with NAM (5 mM) for the indicated time period. The protein association between Flag-MDH2 and endogenous GOT2 was determined by Western blot
analysis.
G Cartoon representation of GOT2 structure (PDB ID: 3PDB) (Han et al 2011) made by Pymol (www.pymol.org). Three putative lysine residues (i.e., K159, K185, and
K404) were labeled in red. See also Supplementary Fig S3.
H Mapping the major lysine residue(s) of acetylation in GOT2 whose acetylation can affect protein interaction between GOT2 and MDH2. Putative acetylated residues
were divided into six groups according to their position in the structure of GOT2. Each group of putative acetylated lysine (K) sites was mutated to arginine (R), and
the deacetylated mimic K-to-R mutants were examined for their protein association with ectopically expressed Myc-MDH2 by Western blot analysis.
I GOT2 coupled with MDH2 shows a high level of K159 acetylation. Flag-GOT2 was overexpressed in HEK293T cells without or with co-overexpression of Myc-MDH2.
These transfected cells were treated with NAM (5 mM) for 5 h. Double immunoprecipitation was performed to obtain the Flag-GOT2 from the Myc-MDH2
immunoprecipitates (Ppt, supposed to be GOT2 bound with MDH2). The remaining supernatants (Sup, supposed to be GOT2 not bound with MDH2) were also
harvested and precipitated by Flag antibody to test the K159 acetylation level of Flag-GOT2 by Western blot analysis.
J The 3KQ/R mutations do not change GOT2 enzyme activity. Wild-type and 3K mutant GOT2 proteins were overexpressed and purified from E. coli, and the enzyme
activity of GOT2 was determined as described in “Materials and Methods”. Shown are average values with standard deviation (SD) of triplicated experiments.
n.s. = not significant for the indicated comparison.
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found that the level of K159 acetylation in Flag-GOT2 was increased
by as much as 3.67-fold and 3.02-fold in Panc-1 cells treated with
glucose (12 mM) and glutamine (2 mM), respectively (Fig 2C and
D). By using the recombinant GOT2K159ac protein purified from
E. coli as the standard, we found that 14–16% of endogenous GOT2
was acetylated at K159 in Panc-1 cells in culture medium containing
no glucose and glutamine, while the K159 acetylation level of
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Figure 2. Glucose and glutamine promote GOT2 acetylation and GOT2–MDH2 association.
A, B Glucose and glutamine increase GOT2 K159 acetylation and GOT2–MDH2 association in HEK293T cells. Flag-GOT2 and Myc-MDH2 were overexpressed in cells
treated with increased concentrations of glucose (A) or glutamine (B) for 6 h. GOT2 proteins were purified by Flag beads, and the K159 acetylation level of GOT2
and its protein association with Myc-MDH2 were determined by Western blot analysis.
C, D Glucose and glutamine increase GOT2 K159 acetylation in Panc-1 cells. Flag-GOT2 was overexpressed in cells treated with different concentrations of glucose (C)
and glutamine (D) for 4 h. GOT2 proteins were purified by Flag beads, and the K159 acetylation level of GOT2 was determined by Western blot analysis. Relative
GOT2 K159 acetylation levels were normalized against Flag protein levels.
E, F Quantification of the percentage of K159-acetylated endogenous GOT2 in Panc-1 cells. Recombinant fully K159-acetylated GOT2 was loaded onto the same gel,
together with endogenous GOT2 from Panc-1 cells treated without or with glucose (12 mM) (E) or glutamine (2 mM) (F) for 4 h. GOT2 protein and K159
acetylation were detected by Western blot. The percentages of K159 acetylation in GOT2 were calculated after normalizing against GOT2 protein levels.
G, H 3K mutant GOT2 displays negligible response in changing protein association with MDH2 after glucose or glutamine treatment. Panc-1 cells with GOT2 knockdown
and re-expression of wild-type or 3K mutant GOT2 were treated with glucose (G) or glutamine (H) at the indicated concentrations for 4 h. The protein association
between Flag-tagged wild-type or 3K mutant GOT2 and endogenous MDH2 was determined by Western blot analysis.
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were maintained with glucose (12 mM) and glutamine (2 mM),
respectively (Fig 2E and F). We then generated GOT2 knockdown
Panc-1 cells, in which we stably expressed GOT2 variants (Supple-
mentary Fig S7), and found that glucose or glutamine treatment
significantly increased the association of wild-type GOT2 with
MDH2 (Fig 2G and H). As compared to wild-type GOT2, acetylation-
mimetic 3KQ mutant GOT2 displayed stronger association with
MDH2, but this protein interaction was not affected by glucose or
glutamine treatment (Fig 2G and H). In contrast, deacetylation-
mimetic 3KR mutant GOT2 was incapable to bind with endogenous
MDH2 in cells without or with glucose/glutamine treatment (Fig 2G
and H). These results further support the notion that both glucose
and glutamine can increase GOT2 3K acetylation, thereby promoting
GOT2–MDH2 association.
SIRT3 deacetylates GOT2 and impairs its association with MDH2
Our earlier observation that NAM increased GOT2 acetylation and
association with MDH2 led us to investigate which NAD+-depen-
dent SIRT(s) is involved in GOT2 deacetylation. Given that GOT2
is localized in the mitochondria, we examined whether mitochon-
drial SIRTs, SIRT3–5 (Imai & Guarente, 2010), could deacetylate
GOT2 and affect its function. We found that GOT2 directly inter-
acted with SIRT3, but not SIRT4 and SIRT5 (Fig 3A). In agreement
with this, the interaction between endogenous GOT2 and SIRT3
proteins was readily detected in HEK293T cells (Fig 3B). Co-over-
expression of SIRT3, but not SIRT4 and SIRT5, greatly decreased
the acetylation level of ectopically expressed GOT2 (Fig 3A). When
GOT2 was co-expressed with a catalytically inactive mutant of
SIRT3, SIRT3H248Y (Schwer et al, 2002), the K159 acetylation level
of GOT2 was unchanged (Fig 3C). Moreover, co-expression of wild-
type SIRT3, but not the catalytically inactive SIRT3H248Y mutant,
impaired the protein interaction between Flag-GOT2 and Myc-
MDH2 (Fig 3D). Conversely, transient knockdown of SIRT3 in
HEK293T cells increased the K159 acetylation level of Flag-GOT2
and enhanced the interaction between Flag-GOT2 and endogenous
MDH2 (Fig 3E). The acetylation-deficient 3KR mutant GOT2
displayed negligible binding with endogenous MDH2 in HEK293T
cells, and knocking down SIRT3 did not affect its association with
MDH2 (Fig 3E). Furthermore, transient knockdown of SIRT3 in
HEK293T cells diminished the effect of high glucose or glutamine
on changing the K159 acetylation level of Flag-GOT2 (Fig 3F and
G). Collectively, these results suggest that the mitochondrial SIRT3
is the major deacetylase of GOT2 and that the effect of GOT2 acet-
ylation on promoting GOT2–MDH2 association is counted by
SIRT3.
Moreover, it has previously been reported that Sirt3 expression is
up-regulated in mouse tissues during fasting (Hirschey et al, 2010).
In agreement, we found that Sirt3 protein expression was indeed
increased in the liver and white adipose tissues of overnight-fasted
mice when compared to control-fed animals (Fig 3H and I). Impor-
tantly, Got2 protein expression was not changed in mouse liver and
white adipose during fasting, but the K159 acetylation level of Got2
was profoundly decreased in both tissues (Fig 3H and I), highlight-
ing the physiological relevance of SIRT3-dependent GOT2 3K acety-
lation in vivo.
GOT2 acetylation stimulates ATP production and suppresses
ROS levels
NAD+ and NADH play a pivotal role in cellular metabolism, acting
as coenzymes in numerous central housekeeping redox reactions.
The cytosolic ratio between the reduced and the oxidized forms
(NADH/NAD+) maintains cellular redox homeostasis and has been
considered as a cellular metabolic readout (Christensen et al, 2014).
In addition to the malate–aspartate shuttle, two other pathways are
also known to regulate the cytosolic NADH/NAD+ ratio in the cell,
including lactate dehydrogenase (LDH)-catalyzed reversible oxida-
tion of lactate to pyruvate, and glycerol-3-phosphate dehydrogenase
(GPDH)-mediated glycerol phosphate shuttle. In this study, we
found that when Panc-1 cells were treated with oxamate, a specific
LDH inhibitor (Novoa et al, 1959), the cytosolic NADH level was
significantly increased (by 39%, P < 0.001, Fig 4A), supporting the
concept that LDHA is important for the anaerobic conversion of
NADH to NAD+ in the cytosol. Moreover, in Panc-1 cells, inhibition
of the malate–aspartate shuttle and the glycerol phosphate shuttle
by AOA [a specific malate–aspartate shuttle inhibitor (Eto et al,
1999)] and epigallocatechin-3-gallate [EGCG, a multi-functional
agent which can inhibit GPDH (Kao et al, 2010)], respectively, led
to a significant increases in the cytosolic NADH level (by 25%,
Figure 3. SIRT3 is the major deacetylase of GOT2.
A GOT2 interacts with SIRT3, but not SIRT4 and SIRT5. Flag-tagged GOT2 was ectopically expressed in HEK293T cells together with the individual HA-tagged SIRT as
indicated. Proteins were purified by IP with Flag beads, following Western blot to detect SIRTs with an HA antibody.
B Endogenous proteins of GOT2 and SIRT3 interact with each other. SIRT3 protein in HEK293T cells was purified by IP with an anti-SIRT3 antibody, following Western
blot to detect GOT2 with an anti-GOT2 antibody.
C GOT2 deacetylation is dependent on SIRT3 catalytic activity. Flag-tagged GOT2 was ectopically expressed in HEK293T cells together with HA-tagged wild-type SIRT3
and a catalytically inactive mutant, SIRT3 H248Y. GOT2 proteins were purified by Flag beads, following Western blot to detect GOT2 K159 acetylation.
D SIRT3 impairs the protein interaction between GOT2 and MDH2. HEK293T cells were transfected with the plasmids as indicated. GOT2 proteins were purified by
Flag beads, and their protein interaction with Myc-MDH2 was determined by Western blot.
E Knockdown of SIRT3 increases GOT2 K159 acetylation and enhances GOT2–MDH2 association. HEK293T cells with or without transient SIRT3 knockdown were
transfected with the plasmids as indicated. GOT2 proteins were purified by Flag beads, and the K159 acetylation level of GOT2 and its protein association with
endogenous MDH2 were determined by Western blot analysis.
F, G Knockdown of SIRT3 diminishes the effect of glucose or glutamine on changing GOT2 K159 acetylation. Flag-tagged GOT2 was ectopically expressed in HEK293T
cells without or with transient SIRT3 knockdown. These cells were treated with different concentrations of glucose (F) and glutamine (G) as indicated. GOT2
proteins were purified by Flag beads, and the K159 acetylation level of GOT2 was determined by Western blot analysis.
H, I Up-regulation of Sirt3 leads to decreased Got2 K159 acetylation in mouse tissues during fasting. C57BL/6 mice (male, 20 weeks; n = 2 per group) were fed a normal
chow diet or fasted overnight. Upon sacrifice, mouse liver and white adipose tissues were harvested, and the levels of the indicated proteins were determined by
Western blot analysis.
▸
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P < 0.001 for AOA treatment and by 15%, P < 0.01 for EGCG treat-
ment) (Fig 4A). These findings indicate that the malate–aspartate
shuttle contributes more than the glycerol phosphate shuttle to regu-
late cytosolic NADH redox homeostasis in Panc-1 cells.
Similar to AOA treatment, knocking down GOT2 could also effec-
tively inhibit the malate–aspartate shuttle, resulting in a significant
increase (by 1.3-fold; P < 0.01) in the cytosolic NADH level in Panc-1
cells (Supplementary Fig S8A). Concomitantly, GOT2 knockdown
Low glucose 
 (7 days) 
Living cell  
(PI and Annexin V 
negative,%) 
Apoptotic cell 
 (PI and/or Annexin V
positive,%) 
shGOT2+GOT2 53.8 46.1 
shGOT2+GOT23KR 52.2 47.7 
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led to a substantial reduction in the mitochondrial NADH level (by
33%; P < 0.01) (Supplementary Fig S8B), affirming the vital role
of GOT2 in controlling the net transfer of cytosolic NADH into
mitochondria. As a result, GOT2 knockdown significantly reduced
ATP production (by 26%; P < 0.01) in Panc-1 cells (Supplementary
Fig S8C). Moreover, in these stable Panc-1 cells with GOT2 knock-
down, we found that re-expression of acetylation-mimetic 3KQ
mutant GOT2 led to a significant (P < 0.05) reduction in the cyto-
solic NADH level as compared to wild-type-rescued cells when
treated without or with glucose (i.e., 0 and 12 mM glucose)
(Fig 4B). Meanwhile, 3KQ mutant GOT2-rescued cells displayed a
significant (P < 0.05 or P < 0.01) increase in the mitochondrial
NADH level as compared to wild-type-rescued cells when treated
without or with glucose (Fig 4C), suggesting that GOT2 3K acetyla-
tion promotes the net transfer of cytosolic NADH into mitochon-
dria. On the other hand, re-expression of the acetylation-deficient
3KR mutant GOT2, which fails to interact with MDH2, led to a
significant (P < 0.05) increase in the cytosolic NADH level and
concomitantly a significant (P < 0.05) decrease in the mitochon-
drial NADH level when compared to wild-type-rescued cells
exposed to high glucose (12 mM) (Fig 4B and C). The effect of
3KR mutant GOT2 on changing the cytosolic and mitochondrial
NADH levels was, however, not observed in rescued cells treated
with no glucose (Fig 4B and C). More importantly, we found that
the ratio of NADH/NAD+ was significantly increased (by 1.4-fold;
P < 0.01) in the mitochondria of 3KQ mutant GOT2-rescued cells
when compared to wild-type-rescued cells exposed to high glucose
(Fig 4D). This result further supports the physiological relevance
and importance of GOT2 acetylation for regulating mitochondrial
NADH/NAD+ redox. In agreement with this, 3KQ mutant GOT2
significantly (P < 0.01) increased ATP levels in rescued cells
treated without or with glucose, while 3KR mutant GOT2 had the
opposite effect on ATP production when rescued cells were
exposed to high glucose (Fig 4E).
Besides ATP production, the malate–aspartate shuttle may also
regulate NADPH production to maintain the cellular redox state
(Son et al, 2013). In agreement with this, we found that GOT2
knockdown led to a significant reduction (by ~50%; P < 0.01) in
the NADPH/NADP+ ratio in Panc-1 cells (Supplementary Fig S8D).
As a result, higher ROS levels were observed in GOT2 knockdown
cells under non-stressed condition or exposed to menadione, a
quinone compound that induces the production of superoxide radi-
cals (Supplementary Fig S8E). Importantly, re-expression of 3KR
mutant GOT2, which is defective in binding to MDH2 and thus
inhibits the malate–aspartate shuttle activity, significantly decreased
the ratios of NADPH/NADP+ (by 27%; P < 0.001) and GSH/GSSH
(by 42%; P < 0.05) (Fig 4F and G), enhanced ROS (Fig 4H), and
increased ROS-induced cell death (Fig 4I). In contrast, re-expression
of 3KQ mutant GOT2, which binds strongly with MDH2 and thus
stimulates the malate–aspartate shuttle activity, significantly
increased the ratios of NADPH/NADP+ (by 1.2-fold; P < 0.001) and
GSH/GSSH (by 1.4-fold; P < 0.05) (Fig 4F and G). As a result, re-
expression of 3KQ mutant GOT2 suppressed ROS (Fig 4H) and
protected cells from oxidative damage (Fig 4I). Moreover, using an
siRNA approach, we reduced NADK2 expression, NADK2 encoding
a key enzyme responsible for generating mitochondrial NADPH
(Houten et al, 2014) (Supplementary Fig S9A). We found that
knockdown of NADK2 could not block the antioxidant response in
rescued cells expressing 3KQ mutant GOT2 (Supplementary Fig
S9B); this implies that the antioxidative effect of GOT2 3K acetyla-
tion on increasing NADPH production may be independent of
NADK2.
Considering the intimate link between cellular compartments
when it comes to redox potential, we next investigated the effect
of GOT2 3K acetylation on altering the redox status and sirtuin
activity in other cell compartments besides the mitochondrion. To
accurately measure the redox status, we established wild-type or
3K mutant GOT2-rescued cells stably co-expressing cytosolic
Figure 4. GOT2 acetylation regulates mitochondrial NADH/NAD+ redox, cellular ATP production, and NADPH homeostasis.
A The malate–aspartate shuttle, such as LDH, also plays a key role in regulating cytosolic NADH levels in Panc-1 cells. Cells were treated with AOA (1.6 mM, 20 min),
oxamate (5 mM, 20 min), and EGCG (0.5 mM, 20 min). The cytosolic NADH level was measured as described in Materials and Methods.
B, C GOT2 3K acetylation promotes the net transfer of cytosolic NADH into mitochondria. In Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated
proteins, the NADH level in the cytosol (B) and mitochondrion (C) was determined in cell extracts as described in Materials and Methods.
D GOT2 3K acetylation regulates mitochondrial NADH/NAD+ redox in the cell. In Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins,
the ratio of NADH/NAD+ in the mitochondria of cells was measured as described in Materials and Methods.
E GOT2 3K acetylation promotes ATP production. In Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins, ATP production was
determined in cell extracts as described in Materials and Methods.
F GOT2 3K acetylation promotes NADPH production. In Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins, the ratio of NADPH/
NADP+ was determined in cell extracts as described in Materials and Methods.
G GOT2 3K acetylation promotes GSH production. In Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins, the GSH/GSSG ratio was
determined in cell extracts as described in Materials and Methods.
H GOT2 3K acetylation suppresses cellular ROS levels. In Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins, ROS was determined as
described in Materials and Methods in cells under non-stressed condition or exposed to menadione (50 lM for 30 min).
I GOT2 3K acetylation protects cells from oxidative damage. Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins were treated with
increasing concentrations of menadione for 3 h as indicated, and cell viability was determined by counting the remaining adherent cells.
J, K Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins were seeded in a 6-well plate, and the cells were maintained under the
condition of low glucose (0.5 mM, J) or high glucose (12 mM, K). Culture medium was refreshed every day, and cell numbers were counted every 1–2 days over a
period of 7 days.
L, M Panc-1 stable cells in (J, K) were grown under low glucose (0.5 mM) or high glucose (12 mM) for 7 days. The level of histone H3 phosphorylation at Ser10 was
determined by Western blot analysis (L). The percentages of living cells and apoptotic cells were determined by flow cytometry as described in Materials and
Methods (M).
Data information: Shown are average values with standard deviation (SD) of triplicated experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 for the indicated
comparison; n.s. = not significant.
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redox-sensitive green fluorescent protein 1 (roGFP1), which allows
real-time visualization of thiol-disulfide metabolic state in the cyto-
sol of living cells (Dooley et al, 2004). We found that the 3KR
mutant GOT2-rescued cells exhibited significantly (P < 0.05) higher
levels of disulfide (oxidized thiol) than wild-type-rescued cells,
while the 3KQ-rescued cells displayed significantly (P < 0.01)
lower levels of disulfide (Supplementary Fig S10), suggesting that
GOT2 3K acetylation can alter the cytosolic redox status in the
cell. On the other hand, we found that the acetylation levels of
H3K9 and H3K56, both of which are known substrates of nuclear
SIRT1 (Nakahata et al, 2008; Yuan et al, 2009), did not differ
between wild-type and 3K mutant GOT2-rescued cells (Supplemen-
tary Fig S11A). Also, the K100 acetylation level of PGM2, a direct
substrate of cytosolic SIRT2 (Xu et al, 2014), did not differ
between wild-type and 3K mutant GOT2-rescued cells (Supplemen-
tary Fig S11B). These results suggest that GOT2 3K acetylation
may not affect the activity of sirtuins in the nuclear and cytosolic
compartments.
We found that the 3KQ mutant GOT2-rescued cells exhibited a
significant (P < 0.01) reduction in basal respiration when
compared to wild-type and the 3KR mutant GOT2-rescued cells,
while ATP turnover and respiration capacity were not affected by
GOT2 3K acetylation (Supplementary Fig S12). Moreover, the 3KQ
mutant GOT2-rescued cells displayed higher rates of glucose and
glutamine uptake than wild-type rescued cells (Supplementary Fig
S13A and B). Furthermore, GOT2 knockdown significantly inhib-
ited cell proliferation in Panc-1 cells (Supplementary Fig S8F),
supporting the vital role of GOT2 in promoting pancreatic cancer
cell proliferation. To further expand the physiological relevance
and importance of GOT2 acetylation, we examined the effect of
GOT2 3K acetylation on cell proliferation and cell survival during
glucose depletion. We found that acetylation-mimetic 3KQ mutant
GOT2 promoted cell proliferation under the condition of low
glucose (0.5 mM glucose) or high glucose (12 mM) (Fig 4J and K).
The observed growth advantage was in line with higher levels of
histone H3 phosphorylation at Ser10 and reduced apoptosis in the
3KQ-rescued cells under low glucose condition (Fig 4L and M).
These data are consistent with a cell growth-promoting role of
GOT2 acetylation even under stress conditions such as glucose
depletion.
Furthermore, we observed that deacetylation-mimetic 3KR
mutant GOT2 suppressed cell proliferation under the condition of
high glucose (12 mM) (Fig 4K). This led us to test the effect of
SIRT3-mediated GOT2 deacetylation on cell proliferation. In Panc-1
cells stably overexpressing Flag-GOT2, pharmacological activation
of SIRT3 by NMN, the NAD+ precursor, led to significantly
increased levels of intracellular NAD+ (Supplementary Fig S14A)
and decreased levels of K159 acetylation of Flag-GOT2 (Supple-
mentary S14B). Cell growth was, however, not affected by NMN
treatment (Supplementary Fig S14C). It has to be noted that NMN
broadly activates NAD+-dependent enzymes, including SIRT3 and
the other SIRTs. To more specifically test the effect of SIRT3 on
cell proliferation, we generated stable Panc-1 cells co-overexpress-
ing Flag-GOT2 and HA-tagged wild-type or catalytically inactive
mutant SIRT3, and growth of these stable cells was carefully moni-
tored over a period of 6 days. As expected, stable overexpression
of SIRT3, but not SIRT3H248Y mutant, decreased the K159 acetyla-
tion level of Flag-GOT2 (Supplementary Fig S14D). Moreover,
stable overexpression of SIRT3, but not SIRT3H248Y mutant, signifi-
cantly inhibited cell proliferation (Supplementary Fig S14E). These
results suggest that SIRT3 suppresses pancreatic cancer cell prolif-
eration, which is at least in part associated with SIRT3-mediated
GOT2 deacetylation.
Taken together, our results suggest that GOT2 3K acetylation
promotes the net transfer of cytosolic NADH into mitochondria to
stimulate ATP production, increases NADPH production to suppress
ROS, and enhances the uptake of glucose/glutamine, thereby
supporting cultured pancreatic cancer cell proliferation.
GOT2 acetylation promotes cell proliferation and tumor growth
The effect of acetylation on stimulating the function of GOT2 in
both ATP production and ROS suppression prompted us to deter-
mine whether GOT2 acetylation allows for an in vivo growth
advantage for tumor cells, which have increased demand for ATP
and also sustain increased oxidative stress. We performed xeno-
graft experiments using Panc-1 cells in which endogenous GOT2
was knocked down and wild-type or acetylation-mimetic 3KQ
mutant GOT2 was ectopically expressed. Tumor cell growth was
monitored over a period of 8 weeks. We found that the tumor
volumes in nude mice injected with cells re-expressing 3KQ
mutant GOT2 were significantly larger than those from mice
injected with cells re-expressing wild-type GOT2 (tumor size at
8 weeks: 247.4 mm3 vs. 84.6 mm3 for 3KQ mutant vs. wild-type;
P < 0.0001) (Fig 5A). The tumor weight in nude mice injected with
cells re-expressing 3KQ mutant GOT2 was also significantly
Figure 5. GOT2 acetylation promotes tumor growth, and GOT2 K159 acetylation is increased in pancreatic cancer.
A–C GOT2 3K acetylation promotes xenograft tumor growth. Panc-1 stable cells with GOT2 knockdown and re-expressing the indicated proteins (2 × 106 cells) were
injected subcutaneously into the flanks of nude mice. The tumor volume was carefully monitored over the indicated time period (A). At 8 weeks after injection,
tumors from six mice were extracted, photographed, and weighted (B, C).
D GOT2 3K acetylation promotes tumor cell proliferation. Tumor sections from xenografts were prepared for IHC staining, and the PCNA-stained tumor sections were
analyzed by quantifying the PCNA-positive area.
E Clinical cases with increased GOT2 K159 acetylation in human pancreatic tumor tissues. 10 pairs of human pancreatic tumor tissue (shown as T) and adjacent
normal tissue (shown as N) were lysed. The acetylation level of GOT2 at K159 was compared against GOT2 protein by Western blot.
F Clinical cases with decreased SIRT3 protein expression in human pancreatic tumor tissues. 10 pairs of human pancreatic tumor tissue (shown as T) and adjacent
normal tissue (shown as N) were lysed. The SIRT3 protein levels were compared against tubulin by Western blot.
G, H Quantification of GOT2 K159 acetylation and SIRT3 protein expression in clinical cases as described in (E) and (F).
Data information: Shown are average values with standard deviation (SD) of triplicated experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 for the indicated
comparison; n.s. = not significant.
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(P < 0.05) heavier than that from mice injected with cells re-
expressing wild-type GOT2 at 8 weeks after injection (Fig 5B and
C). PCNA staining demonstrated that the 3KQ mutant-expressing
tumor cells were more proliferative than the wild-type GOT2-
expressing cells (Fig 5D). Collectively, these data support the
notion that GOT2 3K acetylation promotes cell proliferation and
tumor growth in vivo.
GOT2 K159 acetylation is increased in pancreatic cancer
The finding that tumors derived from the 3KQ mutant-expressing
Panc-1 cells were more proliferative led us to examine the acetyla-
tion level of GOT2 in clinical samples of primary human pancre-
atic tumors. To this end, we collected a total of 10 pairs of
primary human pancreatic cancer samples (T) with the adjacent
normal pancreatic duct tissues (N) and performed a direct immu-
noblotting analysis to determine the K159 acetylation level of
GOT2. This analysis revealed that, when compared with the
matched normal pancreatic tissues, seven of 10 pancreatic cancer
samples showed significantly (P < 0.001) increased levels of
GOT2 K159 acetylation after normalizing to total GOT2 protein
levels (Fig 5E and G). Furthermore, we found that SIRT3 protein
expression was significantly (P < 0.01) decreased in all the 10
pancreatic cancer samples when compared to their matched
normal pancreatic tissues (Fig 5F and H). The results indicate that
the K159 acetylation level of GOT2 may be a potential biomarker
for pancreatic cancer diagnosis.
Discussion
Reprogramming of metabolic pathways, including elevated glycoly-
sis, is a hallmark of cancer (Ward & Thompson, 2012). In most
cancer cells, glycolysis is highly elevated to meet their increased
energy, biosynthesis, and redox needs. The malate–aspartate shuttle
has been shown to promote the net transfer of cytosolic NADH into
mitochondria to ensure a high rate of glycolysis in diverse cancer
cell lines (Dionisi et al, 1974; Greenhouse & Lehninger, 1976, 1977;
Lopez-Alarcon et al, 1979; Lopez-Alarcon & Eboli, 1986). Inhibition
of the malate–aspartate shuttle by a specific inhibitor, AOA, was
found to impair the conversion of glucose into products of the tri-
carboxylic acid cycle and eventually decrease breast adenocarcinoma
cell proliferation (Thornburg et al, 2008). Moreover, knocking down
GOT1/2 genes, two important components of the malate–aspartate
shuttle, has recently been reported to inhibit cell proliferation and
colony formation in pancreatic cancer cell lines (Son et al, 2013).
These findings suggest that the malate–aspartate shuttle and particu-
larly GOT enzymes are indispensable for maintaining a high rate of
glycolysis to support rapid tumor cell growth. However, very little is
known about how the malate–aspartate shuttle is regulated in
response to the changes of metabolic condition and in proliferative
diseases such as cancer.
In the present study, we have discovered that acetylation of three
lysine residues in GOT2, K159, K185, and K404 (3K), enhances
the protein association between GOT2 and MDH2, two princi-
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Figure 6. A working model illustrating regulation of the malate–aspartate shuttle by GOT2 acetylation.
Shown is a working model depicting how acetylation of GOT2 at 3K regulates the malate–aspartate shuttle and promotes pancreatic tumor proliferation. In pancreatic tumor
cells, reduced SIRT3 expression leads to an increase of GOT2 acetylation. GOT2 acetylation at 3K enhances the protein interaction between GOT2 and MDH2, thereby
stimulating the net transfer of cytosolic NADH into mitochondria to support ATP production. Meanwhile, GOT2 3K acetylation promotes cellular NADPH production to
suppress ROS that are produced during rapid cell proliferation. Glc, glucose; Gln, glutamine; Asp, aspartate; and Mal, malate.
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malate–aspartate shuttle. Acetylation-promoted GOT2–MDH2 associ-
ation stimulates the malate shuttle activity and thus promotes the net
transfer of cytosolic NADH into mitochondria to support ATP produc-
tion (Fig. 6). Importantly, we found a significant increase of NADH/
NAD+ratio in the mitochondrion of cells in which endogenous GOT2
was depleted and the acetylation-mimetic 3KQ mutant was ectopi-
cally expressed (knockdown and put-back experiment). This result
indicates that the increased mitochondrial NADH level is most
likely caused by the enhanced NADH transfer from cytosol to mito-
chondria, rather than reduced NADH oxidation at the level of respira-
tory chain complex I, supporting the physiological relevance of GOT2
3K acetylation for regulating mitochondrial NADH/NAD+redox.
Furthermore, our results also demonstrate that GOT2 3K acetyla-
tion stimulates the production of NADPH and helps in the defense
against ROS that are produced during rapid cell proliferation
(Fig. 6). Moreover, we have provided evidence showing that SIRT3
is the major deacetylase of GOT2. Besides GOT2, SIRT3 can deacety-
late multiple other substrates that also contribute, directly or indi-
rectly, to cellular ROS defense, including IDH2 (Yu et al, 2012),
SOD2 (Chen et al, 2011), and ALDH2 (Lu et al, 2011). Among these
metabolic enzymes, GOT2 converts Glu and OAA to a-KG and Asp
to promote a series of reactions, including malate decarboxylation
and production of NADPH that is the key metabolite for maintaining
the redox status; IDH2 is another major source of reductant NADPH;
SOD2 scavenges ROS through catalyzing the detoxification of super-
oxide into oxygen and hydrogen peroxide; and ALDH2 possesses
the antioxidant property by oxidizing and detoxify aldehydes. Nota-
bly, deacetylation by SIRT3 stimulates the activity of SOD2 and
IDH2, but inhibits the activity of ALDH2. Moreover, deacetylation
by SIRT3 may not affect the enzyme activity of GOT2 itself, but can
impair the protein association between GOT2 and MDH2 and there-
fore inhibit the malate–aspartate shuttle activity. These examples
demonstrate the complexity of SIRT3 in regulating enzymes
involved in cellular redox regulation, supporting a notion that meta-
bolic reactions are highly coupled and interconnected. In the current
study, we have demonstrated that the main function of SIRT3-medi-
ated GOT2 deacetylation is to regulate its binding with MDH2 and
thus the malate–aspartate NADH shuttle activity, mitochondrial
NADH/NAD+ redox and ATP production. Reduced activity of GOT2
in ROS defense following SIRT3-deacetylation, we believe is offset
by the reduced GOT2–MDH2 association, malate–aspartate shuttle,
and ATP production. To the best of our knowledge, this is the
first study to show regulation of the malate–aspartate shuttle activ-
ity/function at a post-translational level. Whether lysine acetylation
could regulate cytoplasmic GOT1–MDH1 interaction, in other
words, whether lysine acetylation is specific to regulate mitochon-
drial GOT2–MDH2 association, needs further investigation.
Recent evidence has shown a high metabolic dependency of
PDAC cells on increased use of both glucose and glutamine to
support cell growth (Ying et al, 2012; Son et al, 2013). In this
study, we show that both glucose and glutamine increase GOT2
3K acetylation in Panc-1 cells and that GOT2 3K acetylation plays
a critical role in coordinating glucose and glutamine uptake to
provide energy and support cell proliferation and tumor growth. It
raises the possibility that drugs inhibiting GOT2 3K acetylation
may merit exploration as a therapeutic agent especially for pancre-
atic cancer. Our current study has identified SIRT3 as the major
deacetylase of GOT2. Accumulating evidence has demonstrated
that SIRT3 may have a dual role in cancer development, acting as
either oncogene or tumor suppressor by targeting a series of key
substrates and their relevant pathways in cancer (Chen et al,
2014). In the present study, we found that SIRT3 overexpression
led to decreased GOT2 K159 acetylation and significantly inhibited
cell proliferation in Panc-1 cells. Moreover, we show that SIRT3
expression is broadly reduced in pancreatic cancer tissues compared
to adjacent normal tissues, and the observed reduction in SIRT3
expression is in parallel with an increase in GOT2 K159 acetylation
in pancreatic cancer tissues. Our findings not only provide direct
evidence showing GOT2 acetylation in vivo, but also reveal that
SIRT3 may function as a tumor suppressor in pancreatic cancer with
a potential role in deacetylating GOT2 and inhibiting the malate
NADH shuttle activity.
Materials and Methods
For more details about antibodies, chemicals, plasmids, cell culture
and transfection, immunoprecipitation and Western blotting,
measurement of intracellular ATP, measurement of intracellular
NADPH and NADP+, measurement of mitochondrial NADH and
NAD+, measurement of intracellular GSH, GSSG, and NAD+,
measurement of intracellular ROS, measurement of cytosolic redox
status, measurement of cell respiration, flow cytometry, and
immunohistochemistry, please refer to the Supplementary
Experimental Procedures.
Protein expression and purification
Wild-type and 3K mutant GOT2 proteins (30–430 amino acid) were
overexpressed in E. coli strain BL21 (DE3). 0.5 mM IPTG was added
into the bacterial culture to induce protein expression till OD600
reached 0.6–0.8. After that, the cells were harvested and recombi-
nant proteins were purified by using affinity chromatography (GE
Healthcare) and then stored at 80°C for further analysis. Protein
concentrations were determined by the Bradford method using a
Bio-Rad Protein Assay Kit (Bio-Rad).
The K159 site-specifically acetylated GOT2 was expressed in
E. coli as previously described (Neumann et al, 2008). In short,
amino acids 30–430 of GOT2 were cloned into pTEV-8 vector with
amber codon being incorporated at lysine 159 (AAG to TAG by
site-directed mutagenesis). The E. coli strain BL21 (DE3) was
transformed with three plasmids, pAcKRS-3, pCDF PylT-1, and
pTEV-8-GOT2. Cells were grown overnight in LB containing specti-
nomycin (50 lg/ml), kanamycin (50 lg/ml), and ampicillin
(150 lg/ml) at 37°C till OD600 reached 0.6–0.8. The culture was
supplemented with 20 mM NAM and 2 mM acetyllysine (AcK,
Sigma). Protein expression was induced at 37°C by addition of
0.5 mM of isopropyl-1-thio-D-galactopyranoside (IPTG) for 16 h.
Afterward, the cells were harvested, and the K159-acetylated GOT2
protein was purified and then stored at 80°C till further analysis.
GOT2 enzyme activity assay
The enzyme activity of GOT2 was determined by using a Glutamate-
Oxaloacetate Transaminase Activity Assay Kit (Sigma). In short, the
GOT2 protein was mixed with the assay buffer and incubated for
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2 min at 37°C in darkness. The change in absorbance at 450 nm
was measured every 30 s for 10 min at 37°C in a SpectraMax M5
Microplate Reader (Molecular Devices). Each sample was analyzed
in triplicate, and the enzyme activity of GOT2 was calculated follow-
ing the manufacturer’s instruction.
Generation of knockdown and put-back cell lines
To generate stable GOT2 knockdown cell pools in Panc-1 cells,
shRNA targeting GOT2 was constructed, and retrovirus was
produced using a two-plasmid packaging system as previously
described (Christofk et al, 2008). The shRNA targeting sequence for
GOT2 is 50-GGAATCTCTTTGCGTTCTTTG-30. The pMKO.1-puro
shRNA construct was co-transfected with vectors expressing the gag
and vsvg genes into HEK293T cells. Retroviral supernatant was
harvested 36 h after transfection and mixed with 8 lg/ml polybrene
to increase the infection efficiency. Panc-1 cells were infected with
the retrovirus and selected in 2 lg/ml puromycin for 1 week.
To generate GOT2 knocking down and putting back stable cell
pools in Panc-1 cells, four silent nucleotide substitutions were intro-
duced into Flag-tagged human wild-type or 3KQ mutant GOT2 in
the sequence corresponding to the shRNA-targeted region. shRNA-
resistant GOT2 was cloned into the retroviral pQCXIH-hygro vector
and co-transfected with vectors expressing the gag and vsvg genes in
HEK293T cells to produce retroviruses, which were then used to
transduce Panc-1 cells, following a selection in 350 lg/ml hygromy-
cin for 3 weeks.
Moreover, to generate cells with transient knockdown of NADK2
or SIRT3 gene, we utilized siRNAs against NADK2 or SIRT3 (Invitro-




Measurement of mitochondrial and cytosolic NADH levels
Mitochondrial and cytosolic NADH levels were measured after cali-
bration of Frex and Peredox fluorescence in living cells expressing
recombinant Frex and Peredox protein, respectively (Hung et al,
2011; Zhao et al, 2011). After transfection for 30 h, Panc-1 cells
were harvested by trypsinization and were washed and re-
suspended in PBS. The aliquots of cells were incubated at 37°C with
different inhibitors (i.e., EGCG, oxamate, and AOA), and fluores-
cence excited at 485 nm (Frex) and 400 nm (Peredox) were
measured by a Spectra Max M5 microplate reader (Molecular
Devices) with emission filter 528 nm. Fluorescence values were
background-corrected by subtracting the intensity of Panc-1 cell
samples not expressing Frex or Peredox. All the samples were run
in triplicate.
Cell proliferation and xenograft studies
Panc-1 stable cells with endogenous GOT2 knockdown and put-
back of wild-type or 3K mutant GOT2 (5 × 104 cells) were seeded
in 6-well plates under the condition of low glucose (0.5 mM)
or high glucose (12 mM). Culture medium was refreshed every
day, and cell numbers were counted every 1–2 days over a period
of 7 days.
Nude mice (nu/nu, male, 6–8 weeks old) were injected subcuta-
neously with Panc-1 stable cells with endogenous GOT2 knockdown
and re-expression of wild-type or 3KQ mutant GOT2 (2 × 106 cells).
The diameters of tumors were measured every 7 days during a total
period of 56 days. Around 8 weeks after injection, the tumors were
dissected and analyzed.
Human pancreatic cancer samples
Human pancreatic cancer samples were collected by the Zhejiang
Cancer Research Institute, Zhejiang Province Cancer Hospital. A
physician obtained informed consent from the patients. The proce-
dures related to human subjects were approved by the Ethics
Committee of the Institutes of Biomedical Sciences (IBS), Fudan
University. Direct immunoblotting for these samples was performed
as described above.
Statistics
Statistical analyses were performed with a two-tailed unpaired
Student’s t-test. All data shown represent the results obtained from
triplicated independent experiments with standard errors of the
mean (mean  SD). P < 0.05 was considered statistically signifi-
cant.
Supplementary information for this article is available online:
http://emboj.embopress.org
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